Health-related quality of life outcomes in a Phase 2b Randomized Trial evaluating the effectiveness and safety of Probiotic Peanut Oral Immunotherapy
Melanie Lloyd(Royal Children's Hospital), Mimi L.K. Tang(Royal Children's Hospital), Paxton Loke(Royal Children's Hospital), Marnie Robinson(Royal Children's Hospital), Francesca Orsini(Murdoch Children's Research Institute), Michael Gold(National Centre for Immunisation Research & Surveillance), Sarah Ashley(Murdoch Children's Research Institute), Sigrid Pitkin(Murdoch Children's Research Institute), Dean Tey(Royal Children's Hospital), Susan L. Prescott(Institute for Respiratory Health), Jessica Metcalfe(The Kids Research Institute Australia), Ee Lyn Su(Royal Children's Hospital), Katrina J. Allen(Royal Children's Hospital), Audrey Dunn Galvin(University College Cork), Adriana Chebar Lozinsky(Murdoch Children's Research Institute), Christine Axelrad(Murdoch Children's Research Institute), Michael O’Sullivan(United States Government Publishing Office)
Cited by 0
Related Papers
Influence of maternal obesity on the long-term health of offspring
|The Lancet Diabetes & Endocrinology|2016|1k
International consensus guidelines for the diagnosis and management of food protein–induced enterocolitis syndrome: Executive summary—Workgroup Report of the Adverse Reactions to Foods Committee, American Academy of Allergy, Asthma & Immunology
|Journal of Allergy and Clinical Immunology|2017|675
Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life
|The Lancet Respiratory Medicine|2018|592
Administration of a probiotic with peanut oral immunotherapy: A randomized trial
|Journal of Allergy and Clinical Immunology|2015|436
The epidemiology of anaphylaxis in Europe: a systematic review
|Allergy|2013|406